Yi Chang
Directeur/Bestuurslid bij NONGFU SPRING CO., LTD.
Actieve functies van Yi Chang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NONGFU SPRING CO., LTD. | Directeur/Bestuurslid | 06-03-2020 | - |
| Independent Dir/Board Member | 06-03-2020 | - | |
| COWEALTH MEDICAL CHINA CO.,LTD. | Directeur/Bestuurslid | 22-03-2019 | - |
| Independent Dir/Board Member | 22-03-2019 | - | |
| China Institute of Internal Audit | Corporate Officer/Principal | - | - |
| Asian Development Bank China | Corporate Officer/Principal | - | - |
| Shanghai Advanced Institute of Finance | Corporate Officer/Principal | 01-07-2018 | - |
| Grant Thornton LLP (China) | Corporate Officer/Principal | - | - |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Directeur/Bestuurslid | 19-01-2021 | - |
| Independent Dir/Board Member | 19-01-2021 | - |
Loopbaan van Yi Chang
Eerdere bekende functies van Yi Chang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Directeur/Bestuurslid | 30-07-2021 | 21-05-2024 |
| Independent Dir/Board Member | 30-07-2021 | 21-05-2024 | |
| LAKESHORE BIOPHARMA CO., LTD | Directeur/Bestuurslid | - | 09-12-2023 |
| Independent Dir/Board Member | - | 09-12-2023 | |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Opleiding van Yi Chang
| National Taiwan University | Undergraduate Degree |
| University of Missouri | Graduate Degree |
| Texas Tech University | Doctorate Degree |
Statistieken
Internationaal
| China | 12 |
| Verenigde Staten | 4 |
| Taiwan | 2 |
Operationeel
| Corporate Officer/Principal | 7 |
| Director/Board Member | 5 |
| Independent Dir/Board Member | 5 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| NONGFU SPRING CO., LTD. | Consumer Non-Durables |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Retail Trade |
| COWEALTH MEDICAL CHINA CO.,LTD. | Health Technology |
| LAKESHORE BIOPHARMA CO., LTD | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
| China Institute of Internal Audit | |
| Asian Development Bank China | Government |
Marcum Asia CPAs LLP
 Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
| Grant Thornton LLP (China) | |
| Ernst & Young (China) | |
| Texas State Board of Public Accountancy | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
